Fermentation is one of the key technologies for efficient, economical, and environmentally friendly industrial protein production. Our process development experts can create robust and reproducible upstream fermentation processes for you. We combine scientific knowledge with process development expertise to improve strain productivity for almost any project. Whether you are seeking microbial fermentation process development for small-scale, preclinical evaluation and proof-of-concept studies, or seeking a cGMP-compliant clinical or commercial-scale process, CD Formulation can provide you with customized solutions.
Fermentation technology is a biochemical process that uses microorganisms (such as bacteria, yeast, etc.) to metabolize organic matter. By controlling temperature, humidity, oxygen, pH and other conditions, the metabolic activities of microorganisms are used to produce enzymatic hydrolysis, oxidation-reduction, acidification and alkalization, etc., so that the organic matter in the raw materials undergoes various chemical changes to achieve the purposes of processing, degradation, extraction, fermentation, etc. In the production of protein drugs, microbial fermentation technology has been widely used in the large-scale production of high-quality protein drugs due to its short production cycle, low cost, and easy expansion. This process can insert the target gene into microbial cells through genetic engineering technology, and then use equipment such as fermentation tanks for cultivation and production. The specific steps include selecting suitable microbial strains, culturing strains, setting fermentation conditions (such as temperature, pH value, oxygen content, etc.) controlling these parameters, and finally separating, purifying, and purifying the fermentation products to obtain the target protein.
For protein and peptide biologics, robust and flexible upstream fermentation processes need to be implemented to efficiently transfer and scale up to accommodate various scales of production. CD Formulation has flexible facilities and state-of-the-art equipment, as well as extensive experience in optimizing microbial fermentation batch and fed-batch processes, allowing us to efficiently move your protein therapeutics from concept to industrial-scale production.
Our extensive microbial fermentation process development capabilities enable us to develop reproducible and scalable manufacturing processes to accelerate your project to the next stage quickly. Importantly, all of our approaches are tailored to the unique properties of your desired proteins and peptides.
Our fermentation process development services include:
Fig. 1 Flow chart of fermentation process development. (CD Formulation)
Our comprehensive research and development capabilities in microbial fermentation processes enable us to design and develop protein and peptide products that meet your needs - from pilot to small-scale testing to large-scale commercial production, with the highest level of quality control at each stage. We also follow regulatory systems to ensure that our products comply with all state and global regulations and guarantee product quality.
To fully realize the potential of developed strains, we consider the fermentation process development steps from the early stages of the project. The optimal media components are selected based on a detailed understanding of the strain's physiological parameters and using the existing resources of the production partner as much as possible. The scale-up starts with 5L and then increases to 25L to 150L fermenters. We ensure the step-by-step optimization of key bioprocess parameters and ultimately smoothly transfer the bioprocess to your desired production site.
We provide professional scale-up production process design, and equipment design technical services, and can provide pilot production services.
Our fermentation capabilities are developed to include methanol feed, oxygen enrichment, continuous centrifugation, and high-pressure homogenization, ensuring the highest quality and efficiency throughout the manufacturing process. Our cGMP-compliant systems utilize stainless steel fermenters of various sizes. Whether you require small-scale production or large-scale manufacturing, our facilities are tailored to provide the best results for your protein/peptide product.
Published Data
Technology: Fermentation process development.
Journal: Appl Microbiol Biotechnol.
IF: 3.9
Published: 2021
Results:
The authors developed a scalable upstream fermentation process for the RBD219-N1C1 vaccine candidate. Initial fermentation runs were performed in 1-L bioreactors to find growth medium, induction time, and glycerol fed-batch conditions that resulted in an approximately 10-fold increase in RBD219-N1C1 expression levels. Further scale-up experiments in 5-L bioreactors determined the reproducibility of the selected conditions.
Fig. 2 Timepoint SDS-PAGE analysis of pre- and post-induction fermentation samples of the lockdown process. (Lee J, et al., 2021)
CD Formulation's process developers have extensive experience in optimizing microbial fermentation batch and fed-batch processes for the production of different types of protein and peptide biologics. We utilize scalable, benchtop, single-use stirred bioreactor systems to perform the statistical DOE and process optimization studies to develop high-quality, optimal yield protein and peptide products that meet your needs. Please don't hesitate to contact us if you are interested in our services. We look forward to cooperating with you.
References